From the May 2013 Renal & Urology News. Treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia has evolved from surgical therapy to medical monotherapy, and now combination therapy.
From the April 2013 Renal & Urology News. Given the frequency with which these lesions are found, urologists and nephrologists should be familiar with their evaluation.
From the March 2013 Renal & Urology News. Emerging data suggest that thyroid hormone deficiency may be associated with greater cardiovascular morbidity and mortality in this population.
From the February 2013 Renal & Urology News. Urologists typically treat a renal cortical mass without biopsy, but this should be re-evaluated in the era of the incidental small renal cortical neoplasm.
From the January 2013 Renal & Urology News. Scientific speculation suggests that uremic toxins, viral mediators, and immune inhibition could play a role in malignant transformation.
From the December 2012 Renal & Urology News. This review highlights some of the controversies currently surrounding prostate cancer screening.
From the November 2012 Renal & Urology News. The routine incorporation of NMIBC guidelines will reduce variation in care by closing the gap on inappropriate delivery, whether over- or underuse.
From the October 2012 Renal & Urology News. With increased incidence of obesity—and higher caloric and salt intake—in the general population, resistant hypertension is more prevalent than ever.
From the September 2012 Renal & Urology News. Given the intimate anatomical and physiological relationship of the adrenals to the kidney, an understanding of adrenal disease is imperative for urologists and nephrologists alike.
From the August 2012 Renal & Urology News. The management of patients with high-risk prostate cancer represents one of the biggest challenges today, with little consensus on optimal treatment.
This program provides physicians with the most current information about managing patients with neurogenic OAB to improve patient outcomes and quality of life.
Management approaches are outlined for a patient with a history of hypertension, hypercholesterolemia, and nephrolithiasis.
This activity provides instruction on the latest understanding of the pathogenesis and disease course of SLE-related lupus nephritis as well as the classification scheme for lupus nephritis and approaches to treating the condition.
Pre-existing renal osteodystrophy at the time of transplantation, reduced renal function, and transplantation-specific therapies are contributing factors to managing bone disease in renal transplant patients.
From the May 2012 Renal & Urology News: Diagnostics and treatment options for NGB are continually advancing, and clinicians need to remain up-to-date to accurately assess and optimally manage patients.
A case study involving a 65-year-old man with chronic kidney disease and acute attacks of pain, swelling, and erythema in the first metatarsophalangeal joint.
From the March 2012 Renal & Urology News: A case study examines the treatment of hyperuricemia and gout in a 57-year-old postmenopausal renal transplant recipient with intermittent gout attacks.
From the February 2012 Renal & Urology News. Patients who undergo renal transplantation require complex care that involves a diligent, multidisciplinary approach.
From the January 2012 Renal & Urology News: Short-term outcomes from early institutional experiences have confirmed the safety and feasibility of RPN, even for anatomically complex tumors.
From the December 2011 Renal & Urology News: Gout is increasingly recognized in patients with chronic kidney disease, but the proper dosing regimen for traditional agents has not been well studied in this patient group.
From the November 2011 Renal & Urology News: In determining prostate cancer treatment, physicians should discuss preferences, values, and expectations with patients, including life expectancy, adverse events, and costs.
From the October 2011 Renal & Urology News:Therapeutic options for SIADH have been significantly enhanced with the introduction of specific vasopressin receptor antagonists.
From the September 2011 Renal & Urology News: In select patients, the use of intermittent therapy does not appear to negatively affect overall survival and is associated with fewer adverse events and improved quality of life, including better sexual activity.
From the August 2011 Renal & Urology News: Etiology and treatment is clearly defined for infectious prostatic syndromes, but not for chronic pelvic pain syndrome. In addition, patients tend to be heterogeneous in presentation and in response to treatment. Thus a clinical phenotyping system may prove helpful in classifying patients ...
From the July 2011 Renal & Urology News: The complex biological actions of vitamin D suggest its involvement in a host of physiologic processes and in the development of various pathologies. This second installment discusses the harmful effects of low vitamin D levels.
From the June 2011 Renal and Urology News: Research has shown that vitamin D deficiency has a role in the progressive loss of kidney function as well as increased mortality. This article reviews studies that describe the incidence, prevalence, and adverse outcomes of hypovitaminosis D in various populations.
From the May 2011 Renal and Urology News: Experts discuss hypogonadism treatment for patients at risk for or diagnosed with prostate cancer, and define the role testosterone plays in prostate cancer diagnosis, prognosis, and growth.
From the April 2011 Renal and Urology News: Integrate short- and long-term treatment strategies designed to ensure preservation of renal function and better long-term prognosis for patients with IgA nephropathy.
From the March 2011 Renal and Urology News: With renal cell carcinoma on the rise in some populations, urologists and oncologists are rethinking their approach on several points: Has the disease itself changed? Do we need to refine our techniques in treating RCC? How can we improve prognoses?
From the February 2011 Renal and Urology News: There is no consensus on how to manage this heterogeneous growing population, so this article addresses the issues that must be understood to navigate the scenario posed by patients that have had a prior negative biopsy.
From the January 2011 Renal and Urology News: The management of chronic kidney disease-mineral bone disorder (CKD-MBD) is central to the care of patients with kidney disease. Key to these efforts is the availability of clinically accessible biomarkers that can help distinguish between a wide variety of bone and mineral ...